Rationale There has been increasing attention on cannabis use for medical purposes, but
there is currently a lack of data on its epidemiology. Objectives To examine the …

Abstract Background and Aims There is little information on consumption patterns across the
diverse range of cannabis product types. This paper examines trends in consumption …

Cannabidiol (CBD) is a naturally occurring non-psychoactive cannabinoid found in
Cannabis sativa, commonly known as cannabis or hemp. Although currently available CBD …

Cannabidiol (CBD) is a nonpsychoactive phytocannabinoid and hemp derivative
increasingly used in food. Illegal in food at the US federal level, but legal in some states, the …

Background: Cannabidiol (CBD), a major cannabinoid of Cannabis sativa, is widely
consumed in prescription and non-prescription products. While CBD is generally considered …

Background Multimodal analgesia has become the standard of care for pain management
following total knee arthroplasty (TKA). Cannabidiol (CBD) is increasingly utilized in the …

Background Cannabidiol (CBD) is a primary component in the cannabis plant; however, in
recent years, interest in CBD treatments has outpaced scientific research and regulatory …

Introduction: Oral cannabidiol (CBD) product use is increasingly growing among women;
however, there is a lack of data on sex differences in the pharmacokinetics (PKs) of CBD …

Background Cannabidiol (CBD), a safe, non-intoxicating cannabis component, is growing in
popularity in Europe and worldwide. However, CBD EU regulation is blurry, and consequent …

Background Australian pharmacists currently dispense a wide range of prescription-only
cannabis-based medicines. Recent regulatory changes will expand the role of pharmacists …